Medicare Expansion for GLP-1 Agonists Balances Clinical Gains and Cost Risks
New analysis projects increased Medicare spending with expanded GLP-1 receptor agonist coverage for obesity, highlighting clinical benefits and financial challenges.
Understanding Medicare Coverage for Weight Loss Services
Explore Medicare's coverage options for weight loss services, including eligibility for obesity screening and behavioral therapy. Find out what's included and what isn't.
Medicare Coverage for Wegovy: What's the Latest Update?
Learn about Medicare's coverage of Wegovy for weight loss and cardiovascular risk.